Is Bacitracin + Neomycin + Polymyxin b registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 0 valid registrations of Bacitracin + Neomycin + Polymyxin b.

Is Bacitracin + Neomycin + Polymyxin b approved by the US FDA?

Drugs@FDA lists 1 application product line for Bacitracin + Neomycin + Polymyxin b, including MYCITRACIN (Discontinued).

Active substances

Bacitracin + Neomycin + Polymyxin b

SFDA 2
US FDA 1

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
MULTISOL AEROSOL SPRAY (150 GM )	g	Cutaneous spray · Topical	1 Pressurised container	SAR 13.05	Generic · Prescription	ARAB CENTER FOR PHARMACEUTICALS & CHEMICAL IND. CO.	Withdrawn by regulatory authority · Not Marketed
POLYSPECTRAN EYE & EAR OINTMENT	7500,300,5 IU,IU,mg	Ointment · Auricular use	1 Tube	SAR 11.90	NCE · Prescription	DR. THILO LABORATORIES	Withdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
MYCITRACIN	500 UNITS/GM;EQ 3.5MG BASE/GM;10,000 UNITS/GM	ointment · ophthalmic	PHARMACIA AND UPJOHN	Discontinued

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.